From: Antimicrobial resistance in Africa: a systematic review
Bacteria | No. Studies | HAI N (%) | BSI N (%) | UTI N (%) | AGE N (%) | WI N (%) | Carriage N (%) |
---|---|---|---|---|---|---|---|
S. aureus | 79 | 17 (21.5) | 17 (21.5) | NS | NS | 22 (27.8) | 10 (12.7) |
S. pneumoniae | 24 | NA | 8 (33.3) | 1 (4.2) | NS | NS | 4 (16.7) |
E. coli | 87 | 15 (17.2) | 17 (19.5) | 17 (19.5) | 7 (8) | NS | 2 (2.3) |
Enterobacter spp. | 36 | 3 (8.3) | 8 (22.2) | 8 (22.2) | 1 (2.8) | NS | NA |
Haemophilus influenza | 7 | NA | NA | NS | NS | NS | NA |
CoNSa | 27 | 9 (33.3) | 6 (22.2) | 5 (18.5) | NS | 9 (33.3) | NA |
Citrobacter spp. | 19 | 2 (10.5) | 5 (26.3) | 7 (36.8) | NS | NS | NA |
S. Typhi | 28 | 2 (7.1) | 13 (46.4) | 1 (3.6) | 6 (21.4) | NS | 1 (3.6) |
Pseudomonas aeruginosa | 60 | 17 (28.3) | 11 (18.3) | 8 (13.3) | NS | 20 (33.3) | 2 (3.3) |
Serratia spp. | 7 | 1 (14.3) | 2 (28.6) | NA | NS | NS | 1 (14.3) |
Klebsiella pneumoniae | 75 | 15 (20) | 21 (28) | 15 (20) | NS | 16 (21.3) | 2 (2.7) |
Proteus spp. | 46 | 10 (21.7) | 8 (17.4) | 10 (21.7) | NS | NS | 1 (2.2) |
Acinetobacter spp. | 17 | 5 (29.4) | 7 (41.2) | 1 (5.9) | NS | 4 (23.5) | NA |
Neisseria meningitidis | 1 | NA | NA | NS | NS | NS | NA |
Shigella spp. | 8 | NA | NA | NA | 6 (75) | NS | NA |
Campylobacter spp. | 3 | NA | NA | 1 (33.3) | 3 (100) | NS | NA |
Group A Streptococcus | 18 | 1 (5.6) | 6 (33.3) | NS | NS | 3 (16.7) | 2 (11.1) |
Group B Streptococcus | 2 | NA | NA | NS | NS | NA | NA |
Listeria monocytogenes | 2 | NA | 1 (50) | 1 (50) | NS | NA | NA |
Non-Typhoidal Salmonella spp. | 11 | NA | 9 (81.8) | NS | NA | NS | NA |
Neisseria gonorrhoeae | 11 | NS | NA | 2 (18.2) | NS | NS | NA |
Moraxella spp. | 2 | NS | NA | NS | NS | NS | NA |
Streptococcus spp. | 3 | NA | NA | 1 (33.3) | NS | 1 (33.3) | 1 (33.3) |